Dong-A Pharmaceutical Implements 'GMP IT System' Across All Pharmaceutical Manufacturing Facilities

A panoramic view of Dong-A Pharmaceutical Dangjin Plant located in Hapdeok-eup, Dangjin-si, Chungnam Province. Photo by Dong-A Pharmaceutical

원본보기 아이콘

Dong-A Pharmaceutical announced on April 21 that it has implemented a GMP (Good Manufacturing Practice) IT system at its pharmaceutical manufacturing facilities in Dangjin, Cheonan, and Icheon.

Starting with the Dangjin plant in 2022, Dong-A Pharmaceutical sequentially introduced the GMP IT system to its Icheon and Cheonan plants, establishing a smart process system across all pharmaceutical manufacturing facilities and standardizing its production quality management system.

Specifically, the company has implemented IT systems essential for plant operations, including an Electronic Document Management System (EDMS), Quality Management System (QMS), Laboratory Information Management System (LIMS), Electronic Batch Record (EBR) system, and Laboratory Execution System (LES). This enables real-time monitoring of the entire process from receipt of materials to shipment, resulting in reduced production costs and consistent data management across all three plants.

Previously, all three plants (Dangjin, Cheonan, and Icheon) obtained GMP (Good Manufacturing Practice) certification for excellent pharmaceutical manufacturing facilities, as well as international certifications for environmental and safety management systems, ISO 14001 and 45001, thereby establishing a global-level production system.

A Dong-A Pharmaceutical representative stated, "We introduced the GMP IT system to enhance transparency in the production process and strengthen quality competitiveness at our pharmaceutical manufacturing facilities," adding, "We will continue to strive to build manufacturing facilities for pharmaceuticals that consumers can trust and use with confidence."

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.